IRL-3461

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIRL-3461
Drug Alias NameIRL-3630IRL-3461
ClassificationSmall molecules
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A